{"transactions":[{"id":4618796,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-09-16T00:27:52.000Z","date":"2026-09-11","kind":"sale","planned":false,"acquired":false,"shares":75364,"price":3.403,"value":256463.692,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":598489,"source":{"system":"sec-edgar","filing":"0001140361-26-036688","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704342/000114036126036688/form4.xml","form_type":"4"}},{"id":679820,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-20T21:30:01.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":631,"price":3.381,"value":2133.411,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":673853,"source":{"system":"sec-edgar","filing":"0001140361-26-033915","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126033915/form4.xml","form_type":"4"}},{"id":685333,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-17T21:50:22.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":3493,"price":3.381,"value":11809.833,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":674484,"source":{"system":"sec-edgar","filing":"0001140361-26-033413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126033413/form4.xml","form_type":"4"}},{"id":767706,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-05-21T20:06:05.000Z","date":"2026-05-19","kind":"sale","planned":false,"acquired":false,"shares":662,"price":3.014,"value":1995.268,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":677977,"source":{"system":"sec-edgar","filing":"0001140361-26-022446","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126022446/form4.xml","form_type":"4"}},{"id":778849,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-05-14T20:22:33.000Z","date":"2026-05-13","kind":"sale","planned":false,"acquired":false,"shares":3361,"price":3.606,"value":12119.766,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":678639,"source":{"system":"sec-edgar","filing":"0001140361-26-021321","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126021321/form4.xml","form_type":"4"}},{"id":890464,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-02-20T21:09:54.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":1376,"price":3.338,"value":4593.088,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":682000,"source":{"system":"sec-edgar","filing":"0001140361-26-006317","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126006317/form4.xml","form_type":"4"}},{"id":896253,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-02-18T22:42:54.000Z","date":"2026-02-13","kind":"sale","planned":false,"acquired":false,"shares":12253,"price":3.312,"value":40581.936,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":683376,"source":{"system":"sec-edgar","filing":"0001140361-26-006047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126006047/form4.xml","form_type":"4"}},{"id":904915,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T21:05:24.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":468187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 468,187 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":468187,"derivative":{"exercise_price":3.24,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":468187},"source":{"system":"sec-edgar","filing":"0001140361-26-005410","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126005410/form4.xml","form_type":"4"}},{"id":904914,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-02-13T21:05:24.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":311813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs, one-third (1/3) of which will become fully vested on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":695629,"source":{"system":"sec-edgar","filing":"0001140361-26-005410","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126005410/form4.xml","form_type":"4"}},{"id":992426,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-11-20T21:05:34.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":1646,"price":2.983,"value":4910.018,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":383816,"source":{"system":"sec-edgar","filing":"0001140361-25-042854","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125042854/form4.xml","form_type":"4"}},{"id":1003558,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-11-10T21:25:53.000Z","date":"2025-11-03","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represent RSUs that convert to common stock on a one-for-one basis. The RSUs will become fully vested on November 3, 2026."}],"balance_after":385462,"source":{"system":"sec-edgar","filing":"0001140361-25-041393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125041393/form4.xml","form_type":"4"}},{"id":1044700,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-09-09T20:18:43.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on September 8, 2026, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":285462,"source":{"system":"sec-edgar","filing":"0001140361-25-034422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125034422/form4.xml","form_type":"4"}},{"id":1060113,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-20T21:00:20.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":588,"price":2.996,"value":1761.648,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":135462,"source":{"system":"sec-edgar","filing":"0001140361-25-032090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125032090/form4.xml","form_type":"4"}},{"id":1060112,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-20T21:00:20.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1004,"price":3.065,"value":3077.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":136050,"source":{"system":"sec-edgar","filing":"0001140361-25-032090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125032090/form4.xml","form_type":"4"}},{"id":1063776,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T20:35:01.000Z","date":"2025-08-14","kind":"sale","planned":false,"acquired":false,"shares":12109,"price":3.019,"value":36557.071,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":137054,"source":{"system":"sec-edgar","filing":"0001140361-25-031760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125031760/form4.xml","form_type":"4"}},{"id":1136872,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-05-22T20:05:39.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":587,"price":6.446,"value":3783.802,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":149163,"source":{"system":"sec-edgar","filing":"0001140361-25-020159","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125020159/form4.xml","form_type":"4"}},{"id":1140280,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-05-20T20:05:39.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":946,"price":6.528,"value":6175.488,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":149750,"source":{"system":"sec-edgar","filing":"0001140361-25-019898","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125019898/form4.xml","form_type":"4"}},{"id":1245697,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-02-25T21:01:56.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":3222,"price":10.58,"value":34088.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":150696,"source":{"system":"sec-edgar","filing":"0001140361-25-005846","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125005846/form4.xml","form_type":"4"}},{"id":1269453,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T21:01:37.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":134642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 134,642 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":134642,"derivative":{"exercise_price":9.88,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":134642},"source":{"system":"sec-edgar","filing":"0001140361-25-004297","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125004297/form4.xml","form_type":"4"}},{"id":1269452,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-02-13T21:01:37.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":90358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":153918,"source":{"system":"sec-edgar","filing":"0001140361-25-004297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125004297/form4.xml","form_type":"4"}},{"id":1352532,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-11-25T21:05:14.000Z","date":"2024-11-21","kind":"sale","planned":false,"acquired":false,"shares":1175,"price":13.054,"value":15338.45,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":63560,"source":{"system":"sec-edgar","filing":"0001140361-24-047754","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124047754/form4.xml","form_type":"4"}},{"id":1427477,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-08-20T20:26:32.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":1027,"price":18.504,"value":19003.608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":64735,"source":{"system":"sec-edgar","filing":"0001140361-24-037931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124037931/form4.xml","form_type":"4"}},{"id":1508808,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:29:47.000Z","date":"2023-02-14","kind":"other","planned":false,"acquired":false,"shares":16947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"security","element":"securityTitle","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16947},"source":{"system":"sec-edgar","filing":"0001140361-24-026873","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026873/form4.xml","form_type":"4"}},{"id":1508807,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:29:47.000Z","date":"2022-08-12","kind":"other","planned":false,"acquired":false,"shares":28763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F3","text":"Represents RSUs initially granted on August 12, 2022, which vest in full on August 12, 2025."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RSUs initially granted on August 12, 2022, which vest in full on August 12, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RSUs initially granted on August 12, 2022, which vest in full on August 12, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":28763},"source":{"system":"sec-edgar","filing":"0001140361-24-026873","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026873/form4.xml","form_type":"4"}},{"id":1508806,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-05-20T20:29:47.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":2420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":16947,"derivative":{"underlying":"Common Stock","underlying_shares":2420},"source":{"system":"sec-edgar","filing":"0001140361-24-026873","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026873/form4.xml","form_type":"4"}},{"id":1508805,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-05-20T20:29:47.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":1048,"price":23.35,"value":24470.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":65762,"source":{"system":"sec-edgar","filing":"0001140361-24-026873","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026873/form4.xml","form_type":"4"}},{"id":1508804,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-05-20T20:29:47.000Z","date":"2023-02-14","kind":"other","planned":false,"acquired":true,"shares":16947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"security","element":"securityTitle","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":66810,"source":{"system":"sec-edgar","filing":"0001140361-24-026873","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026873/form4.xml","form_type":"4"}},{"id":1508803,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-05-20T20:29:47.000Z","date":"2022-08-12","kind":"other","planned":false,"acquired":true,"shares":28763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F3","text":"Represents RSUs initially granted on August 12, 2022, which vest in full on August 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting. These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":49863,"source":{"system":"sec-edgar","filing":"0001140361-24-026873","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026873/form4.xml","form_type":"4"}},{"id":1508802,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-05-20T20:29:47.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":2420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":21100,"source":{"system":"sec-edgar","filing":"0001140361-24-026873","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124026873/form4.xml","form_type":"4"}},{"id":1602716,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-03-04T23:48:13.000Z","date":"2024-02-29","kind":"sale","planned":false,"acquired":false,"shares":4100,"price":29.331,"value":120257.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.33 to $29.37. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":18680,"source":{"system":"sec-edgar","filing":"0001140361-24-011168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124011168/form4.xml","form_type":"4"}},{"id":1628586,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-22T01:54:41.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":49091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option represents a right to purchase a total of 49,091 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":49091,"derivative":{"exercise_price":30.01,"expiration_date":"2034-02-16","underlying":"Common Stock","underlying_shares":49091},"source":{"system":"sec-edgar","filing":"0001140361-24-008890","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008890/form4.xml","form_type":"4"}},{"id":1628585,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-02-22T01:54:41.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":16644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"security","element":"securityTitle","label":"F4","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":22780,"source":{"system":"sec-edgar","filing":"0001140361-24-008890","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008890/form4.xml","form_type":"4"}},{"id":1628584,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-02-22T01:54:41.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":3576,"price":29.838,"value":106700.688,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F3","text":"The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement."}],"balance_after":6136,"source":{"system":"sec-edgar","filing":"0001140361-24-008890","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008890/form4.xml","form_type":"4"}},{"id":1637974,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T21:05:43.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":9712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":19367,"derivative":{"underlying":"Common Stock","underlying_shares":9712},"source":{"system":"sec-edgar","filing":"0001140361-24-008360","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008360/form4.xml","form_type":"4"}},{"id":1637973,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-02-16T21:05:43.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":9712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":9712,"source":{"system":"sec-edgar","filing":"0001140361-24-008360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036124008360/form4.xml","form_type":"4"}},{"id":2010748,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-02-16T21:45:43.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":29079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":29079,"derivative":{"underlying":"Common Stock","underlying_shares":29079},"source":{"system":"sec-edgar","filing":"0001140361-23-007486","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123007486/form4.xml","form_type":"4"}},{"id":2010747,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-16T21:45:43.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":87147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 87,147 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":87147,"derivative":{"exercise_price":20.04,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":87147},"source":{"system":"sec-edgar","filing":"0001140361-23-007486","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123007486/form4.xml","form_type":"4"}},{"id":2183929,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2022-08-16T21:24:54.000Z","date":"2022-08-12","kind":"grant","acquired":true,"shares":28763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will become fully vested on August 12, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units will become fully vested on August 12, 2025."}],"balance_after":28763,"derivative":{"underlying":"Common Stock","underlying_shares":28763},"source":{"system":"sec-edgar","filing":"0001140361-22-029888","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122029888/form4.xml","form_type":"4"}},{"id":2183928,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-16T21:24:54.000Z","date":"2022-08-12","kind":"grant","acquired":true,"shares":20318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 20,318 shares of the Issuer's common stock, which will become fully vested and exercisable on August 12, 2025."}],"balance_after":20318,"derivative":{"exercise_price":17.47,"expiration_date":"2032-08-11","underlying":"Common Stock","underlying_shares":20318},"source":{"system":"sec-edgar","filing":"0001140361-22-029888","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036122029888/form4.xml","form_type":"4"}},{"id":2480357,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-08T23:55:24.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 100,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on December 6, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":100000,"derivative":{"exercise_price":23.04,"expiration_date":"2031-12-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001140361-21-040891","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036121040891/form4.xml","form_type":"4"}},{"id":3643621,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option","published_at":"2019-02-21T17:00:56.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":193712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities were issued pursuant to the terms of the Issuer's 2016 Equity Incentive Plan as part of the Reporting Person's annual compensation. One-third of the shares underlying the derivative securities shall vest ratably on an annual basis beginning on February 19, 2020."}],"balance_after":193712,"derivative":{"exercise_price":1.62,"exercise_date":"2020-02-19","expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":193712},"source":{"system":"sec-edgar","filing":"0001144204-19-009335","document":"tv514231_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419009335/tv514231_4.xml","form_type":"4"}},{"id":3786139,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2018-10-22T21:45:55.000Z","date":"2018-04-25","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of restricted stock units (\"RSUs\") granted to the Reporting Person on April 25, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest ratably on an annual basis for three years beginning on April 25, 2018. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest ratably on an annual basis for three years beginning on April 25, 2018. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001144204-18-054834","document":"tv505291_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420418054834/tv505291_4.xml","form_type":"4"}},{"id":3786138,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2018-10-22T21:45:55.000Z","date":"2018-04-25","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of restricted stock units (\"RSUs\") granted to the Reporting Person on April 25, 2017."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001144204-18-054834","document":"tv505291_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420418054834/tv505291_4.xml","form_type":"4"}},{"id":3977804,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Unit","published_at":"2018-04-02T16:06:03.000Z","date":"2018-03-22","kind":"grant","acquired":true,"shares":11052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities were issued pursuant to the terms of the Issuer's 2016 Equity Incentive Plan as part of the Reporting Person's annual compensation. One-third of the shares underlying the derivative securities shall vest ratably on an annual basis beginning on March 22, 2019."}],"balance_after":11052,"derivative":{"exercise_date":"2019-03-22","expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":11052},"source":{"system":"sec-edgar","filing":"0001144204-18-018612","document":"tv490094_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420418018612/tv490094_form4.xml","form_type":"4"}},{"id":3977803,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option","published_at":"2018-04-02T16:06:03.000Z","date":"2018-03-22","kind":"grant","acquired":true,"shares":22105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities were issued pursuant to the terms of the Issuer's 2016 Equity Incentive Plan as part of the Reporting Person's annual compensation. One-third of the shares underlying the derivative securities shall vest ratably on an annual basis beginning on March 22, 2019."}],"balance_after":22105,"derivative":{"exercise_price":3.53,"exercise_date":"2019-03-22","expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":22105},"source":{"system":"sec-edgar","filing":"0001144204-18-018612","document":"tv490094_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420418018612/tv490094_form4.xml","form_type":"4"}},{"id":4345150,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Unit","published_at":"2017-04-26T16:45:57.000Z","date":"2017-04-25","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities were issued pursuant to the terms of the Issuer's 2016 Equity Incentive Plan as part of the Reporting Person's annual compensation. One-third of the shares underlying the derivative securities shall vest ratably on an annual basis beginning on April 25, 2018."}],"balance_after":15000,"derivative":{"exercise_date":"2018-04-25","expiration_date":"2027-04-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001628280-17-004327","document":"wf-form4_149323953987247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/352998/000162828017004327/wf-form4_149323953987247.xml","form_type":"4"}},{"id":4345149,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":21206,"kind":"person","name":"Wilson Martin","position":1,"cik":"0001704342","reported_name":"Wilson Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option","published_at":"2017-04-26T16:45:57.000Z","date":"2017-04-25","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities were issued pursuant to the terms of the Issuer's 2016 Equity Incentive Plan as part of the Reporting Person's annual compensation. One-third of the shares underlying the derivative securities shall vest ratably on an annual basis beginning on April 25, 2018."}],"balance_after":40000,"derivative":{"exercise_price":8.15,"exercise_date":"2018-04-25","expiration_date":"2027-04-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001628280-17-004327","document":"wf-form4_149323953987247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000162828017004327/wf-form4_149323953987247.xml","form_type":"4"}}]}